| Bioactivity | Pentagamavunon-1 (PGV-1), a Curcumin analog with oral activity, targets on several molecular mechanisms to induce apoptosis including inhibition of angiogenic factors cyclooxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF). PGV-1 inhibits NF-κB activation[1]. | ||||||||||||
| Invitro | Pentagamavunon-1 (PGV-1, 1, 2.5, 5, 7.5, 10, 15, and 20 µM) enhances cytotoxic effect of 5-FU on WiDr cells[1].Pentagamavunon-1 (PGV-1, 1, 2.5, 5, and 10 µM) shows different effects on cell cycle progression and induces G2/M arrest[1]. Cell Viability Assay[1]. Cell Line: | ||||||||||||
| Name | Pentagamavunon-1 | ||||||||||||
| CAS | 27060-70-4 | ||||||||||||
| Formula | C23H24O3 | ||||||||||||
| Molar Mass | 348.43 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Pentagamavunon-1
CAS: 27060-70-4 F: C23H24O3 W: 348.43
Pentagamavunon-1 (PGV-1), a Curcumin analog with oral activity, targets on several molecular mechanisms to induce apopto
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.